Literature DB >> 11796622

Induction of an AIDS virus-related tuberculosis-like disease in macaques: a model of simian immunodeficiency virus- mycobacterium coinfection.

Yun Shen1, Dejiang Zhou, Laura Chalifoux, Ling Shen, Meredith Simon, Xuejun Zeng, Xioamin Lai, Yunyuan Li, Prabhat Sehgal, Norman L Letvin, Zheng W Chen.   

Abstract

The mechanism by which human immunodeficiency virus (HIV)-Mycobacterium tuberculosis coinfection facilitates development of HIV-related tuberculosis is poorly characterized. Macaque models of simian immunodeficiency virus (SIV(mac))-Mycobacterium bovis BCG coinfection were employed to explore the pathogenesis of AIDS virus-related tuberculosis. Following BCG coinfection, SIV (SIV)-infected macaques with high viral loads developed an SIV-related tuberculosis-like disease. This disease was characterized clinically by a syndrome of diarrhea, anorexia, weight loss, and altered levels of consciousness and pathologically by the presence of disseminated granulomas. In contrast, SIV(mac)-infected macaques with low viral loads either showed no evidence of BCG-induced disease or developed focal granulomatous lesions. Pathogenic SIV-BCG interactions appeared to play a critical role in triggering the development of this SIV-related tuberculosis-like disease. BCG coinfection enhanced the destruction of CD4(+) T cells in SIV(mac)-infected macaques whose viral loads were high. Reciprocally, exacerbations of SIV disease led to marked suppression of BCG-specific T-cell responses, persistence of the BCG infection, and development of an SIV-related tuberculosis-like disease. Furthermore, development of this SIV-related tuberculosis-like disease was also seen in naïve macaques simultaneously inoculated with SIV(mac) and BCG. These results provide in vivo evidence that coinfection of AIDS virus-infected individuals with an avirulent mycobacterium can lead to development of a tuberculosis-like disease.

Entities:  

Mesh:

Year:  2002        PMID: 11796622      PMCID: PMC127670          DOI: 10.1128/IAI.70.2.869-877.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

Review 1.  Tuberculosis in patients with human immunodeficiency virus infection.

Authors:  P F Barnes; A B Bloch; P T Davidson; D E Snider
Journal:  N Engl J Med       Date:  1991-06-06       Impact factor: 91.245

2.  Infection with Mycobacterium bovis in a patient with AIDS: a late complication of BCG vaccination.

Authors:  E Smith; S Thybo; J Bennedsen
Journal:  Scand J Infect Dis       Date:  1992

3.  Disseminated Mycobacterium bovis infection from BCG vaccination and HIV infection.

Authors:  P Boudes; A Sobel; L Deforges; E Leblic
Journal:  JAMA       Date:  1989-11-03       Impact factor: 56.272

4.  Tuberculosis: a global overview of the situation today.

Authors:  P Sudre; G ten Dam; A Kochi
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

5.  Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire.

Authors:  Y Mukadi; J H Perriëns; M E St Louis; C Brown; J Prignot; J C Willame; F Pouthier; M Kaboto; R W Ryder; F Portaels
Journal:  Lancet       Date:  1993-07-17       Impact factor: 79.321

6.  Quantitative bacillary response to treatment in HIV-associated pulmonary tuberculosis.

Authors:  R J Brindle; P P Nunn; W Githui; B W Allen; S Gathua; P Waiyaki
Journal:  Am Rev Respir Dis       Date:  1993-04

7.  The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods.

Authors:  P M Small; P C Hopewell; S P Singh; A Paz; J Parsonnet; D C Ruston; G F Schecter; C L Daley; G K Schoolnik
Journal:  N Engl J Med       Date:  1994-06-16       Impact factor: 91.245

8.  Human tuberculosis due to Mycobacterium bovis: report of 10 cases.

Authors:  J Sauret; R Jolis; V Ausina; E Castro; R Cornudella
Journal:  Tuber Lung Dis       Date:  1992-12

9.  Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection.

Authors:  B E Jones; S M Young; D Antoniskis; P T Davidson; F Kramer; P F Barnes
Journal:  Am Rev Respir Dis       Date:  1993-11

10.  Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction.

Authors:  M Piatak; M S Saag; L C Yang; S J Clark; J C Kappes; K C Luk; B H Hahn; G M Shaw; J D Lifson
Journal:  AIDS       Date:  1993-11       Impact factor: 4.177

View more
  34 in total

1.  Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections.

Authors:  Yun Shen; Dejiang Zhou; Liyou Qiu; Xioamin Lai; Meredith Simon; Ling Shen; Zhongchen Kou; Qifan Wang; Liming Jiang; Jim Estep; Robert Hunt; Michelle Clagett; Prabhat K Sehgal; Yunyaun Li; Xuejun Zeng; Craig T Morita; Michael B Brenner; Norman L Letvin; Zheng W Chen
Journal:  Science       Date:  2002-03-22       Impact factor: 47.728

Review 2.  Vgamma2Vdelta2+ T cells and anti-microbial immune responses.

Authors:  Zheng W Chen; Norman L Letvin
Journal:  Microbes Infect       Date:  2003-05       Impact factor: 2.700

Review 3.  Immune regulation of gammadelta T cell responses in mycobacterial infections.

Authors:  Zheng W Chen
Journal:  Clin Immunol       Date:  2005-09       Impact factor: 3.969

4.  Immune gene networks of mycobacterial vaccine-elicited cellular responses and immunity.

Authors:  Dan Huang; Liyou Qiu; Richard Wang; Xioamin Lai; George Du; Probhat Seghal; Yun Shen; Lingyun Shao; Lisa Halliday; Jeff Fortman; Ling Shen; Norman L Letvin; Zheng W Chen
Journal:  J Infect Dis       Date:  2006-11-22       Impact factor: 5.226

5.  Analysis of pigtail macaque major histocompatibility complex class I molecules presenting immunodominant simian immunodeficiency virus epitopes.

Authors:  Miranda Z Smith; C Jane Dale; Robert De Rose; Ivan Stratov; Caroline S Fernandez; Andrew G Brooks; Jason Weinfurter; Kendall Krebs; Cara Riek; David I Watkins; David H O'connor; Stephen J Kent
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

6.  A neonatal oral Mycobacterium tuberculosis-SIV prime / intramuscular MVA-SIV boost combination vaccine induces both SIV and Mtb-specific immune responses in infant macaques.

Authors:  Kara Jensen; Myra Grace Dela Pena; Robert L Wilson; Uma Devi K Ranganathan; William R Jacobs; Glenn Fennelly; Michelle Larsen; Koen K A Van Rompay; Pamela A Kozlowski; Kristina Abel
Journal:  Trials Vaccinol       Date:  2013-11-01

Review 7.  The non-human primate model of tuberculosis.

Authors:  D Kaushal; S Mehra; P J Didier; A A Lackner
Journal:  J Med Primatol       Date:  2012-03-20       Impact factor: 0.667

8.  Immune biology of macaque lymphocyte populations during mycobacterial infection.

Authors:  X Lai; Y Shen; D Zhou; P Sehgal; L Shen; M Simon; L Qiu; N L Letvin; Z W Chen
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

9.  Reactivation of latent tuberculosis in cynomolgus macaques infected with SIV is associated with early peripheral T cell depletion and not virus load.

Authors:  Collin R Diedrich; Joshua T Mattila; Edwin Klein; Chris Janssen; Jiayao Phuah; Timothy J Sturgeon; Ronald C Montelaro; Philana Ling Lin; Joanne L Flynn
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

10.  A critical role for CD8 T cells in a nonhuman primate model of tuberculosis.

Authors:  Crystal Y Chen; Dan Huang; Richard C Wang; Ling Shen; Gucheng Zeng; Shuyun Yao; Yun Shen; Lisa Halliday; Jeff Fortman; Milton McAllister; Jim Estep; Robert Hunt; Daphne Vasconcelos; George Du; Steven A Porcelli; Michelle H Larsen; William R Jacobs; Barton F Haynes; Norman L Letvin; Zheng W Chen
Journal:  PLoS Pathog       Date:  2009-04-17       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.